AUNA vs. LFMD, TVTX, EHAB, TSHA, OFIX, VYGR, WGS, FULC, KALV, and ALEC
Should you be buying Auna stock or one of its competitors? The main competitors of Auna include LifeMD (LFMD), Travere Therapeutics (TVTX), Enhabit (EHAB), Taysha Gene Therapies (TSHA), Orthofix Medical (OFIX), Voyager Therapeutics (VYGR), GeneDx (WGS), Fulcrum Therapeutics (FULC), KalVista Pharmaceuticals (KALV), and Alector (ALEC). These companies are all part of the "medical" sector.
LifeMD (NASDAQ:LFMD) and Auna (NYSE:AUNA) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, media sentiment, profitability, community ranking, valuation, risk and institutional ownership.
LifeMD received 22 more outperform votes than Auna when rated by MarketBeat users. However, 100.00% of users gave Auna an outperform vote while only 70.27% of users gave LifeMD an outperform vote.
Auna has a net margin of 0.00% compared to Auna's net margin of -14.75%.
In the previous week, Auna had 3 more articles in the media than LifeMD. MarketBeat recorded 7 mentions for Auna and 4 mentions for LifeMD. Auna's average media sentiment score of 0.48 beat LifeMD's score of 0.38 indicating that LifeMD is being referred to more favorably in the media.
LifeMD presently has a consensus price target of $11.60, suggesting a potential upside of 49.29%. Auna has a consensus price target of $14.15, suggesting a potential upside of 62.27%. Given LifeMD's higher possible upside, analysts plainly believe Auna is more favorable than LifeMD.
Auna has lower revenue, but higher earnings than LifeMD.
35.5% of LifeMD shares are owned by institutional investors. 18.9% of LifeMD shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Summary
LifeMD beats Auna on 6 of the 11 factors compared between the two stocks.
This chart shows the number of new MarketBeat users adding AUNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
